MOCKSVILLE, N.C., March 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the ...
Meet 22nd Century Group, the biotech co. driven by the mission to reduce the harm caused by smoking.
Headquartered in Buffalo, New York, 22nd Century Group is a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research.
MOCKSVILLE, N.C.,, June 26, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice ...
Expansion in 2026 Forecasted to Exceed 5,000 Retail Outlets Nationwide as Consumers Demonstrate Interest in VLN ® Brands VLN ® Remains the Only FDA-Authorized Combustible Cigarette Designed to Reduce ...
MOCKSVILLE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a ...
22nd Century Group, Inc. (XXII) is one of the most interesting stocks in biotechnology right now. The company, which bills itself as a biotechnology company and is based in New York, has developed a ...
On Monday, the company announced an agreement to fund all intellectual property, licensing and sponsored research payments to North Carolina State University through 2025 in equity as part of a deal ...
Repayment of $3.9 Million in Senior Secured Debt Lowers Ongoing Cash Needs and Operating Costs by Eliminating Cash Interest and Amortization Expense Company Balance Sheet Reflects Working Capital to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results